Human platelet antigen (HPA) systems consist of more than 12 biallelic antigen polymorphisms in which a base pair substitution leads to change in an amino acid of a glycoprotein expressed on the platelet (1) . HPA typing is essential in the diagnosis and treatment for a variety of immune neonatal thrombocytopenic diseases such as neonatal alloimmune thrombocytopenia (NAIT), posttransfusion purpura (PTP), and refractoriness to platelet transfusion (1, 2) .
In transfusion medicine, HPA can be serologically typed for phenotypes with immunologic methods. At present, according to the recent developments in molecular biology, DNA typing methods were originally developed to determine the genotypes of HPA systems located on glyco-protein IIIa. It is a major technical improvement to use polymerase chain reaction (PCR) techniques for genomic typing of HPA (3). Not only is it possible to perform HPA typings in severely thrombocytopenic patients and on amniotic fluid cells of the fetus of alloimmunized mothers, but it must be expected that accuracy of the HPA typing will increase considerably, as has been the case with genomic HLA class II typing (3). Finally, the PCR technique combined with allelespecific primers is suitable for accurate largescale typing of platelet donors, which may be useful in special clinical settings (3) .
Of those HPAs, HPA-3 (Bak) is the one that has been widely studied. The variations between populations in this HPA polymorphism would provide so many useful descriptive elements for the epidemiologic study of associated diseases. Here, the author performs a summary on the recent previous reports on the gene frequencies of HPA-3 among different populations. In addition, the study was expanded to include clinical impact of the gene variation and comparison to 89 Gene Frequencies of the Human Platelet Antigen-3
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Summary: Human platelet antigen (HPA) systems consist of more than 12 biallelic antigen polymorphisms in which a base pair substitution leads to change in an amino acid of a glycoprotein expressed on the platelet. HPA-3 is a HPA that is mentioned for possible induction of neonatal alloimmune thrombocytopenia, posttransfusion purpura, and platelet refractoriness. A summary is presented of previous reports on the gene frequencies of HPA-3 among different populations. The frequency of HPA-3a and -3b ranges from 0.50 to 0.61 and 0.38 to 0.50, respectively. A significant correlation between the population ethniticity and the gene frequencies was detected in this other HPA systems. The metanalysis was performed and presented in this article.
MATERIALS AND METHODS

Analysis of the Pattern of HPA-3 Gene Polymorphism Among Different Populations
Data mining A literature review was performed concerning the polymorphism of HPA-3 gene from various countries using PubMed (www.pubmed.com) as search engine. The reports with complete data on the pattern of HPA-3 polymorphism are selected. The allele frequencies reported from all detected reports were recorded and used as primary data for further analysis.
Metanalysis
The frequencies from all reports were analyzed using a method similar to the phylogenetic study. Briefly, the frequency difference between each population pair was calculated and used for comparison (4) . The correlation between the ethnic group population and the gene frequencies was assessed using the regression analysis. A p value equal to or less than 0.05 was accepted as the statistical significant level.
Analysis of the Pattern of HPA-3 Gene Polymorphism and Incidence of Immune Neonatal Thrombocytopenia
Data mining A literature review was performed concerning the correlation between the pattern of HPA-3 gene polymorphism and the incidence of immune neonatal thrombocytopenia in various populations, using PubMed (www.pubmed.com) as search engine. The reports with complete data on incidence on neonatal immune thrombocytopenia and pattern gene polymorphism in the same population were included for further analysis. The allele frequencies reported from all detected reports were recorded and used as primary data for further analysis.
Metanalysis
The frequencies from all reports were further analyzed by descriptive statistical method. Briefly, the correlation between the gene frequencies and incidences of disorders was assessed using regression analysis. A p value equal to or less than 0.05 was accepted as the statistically significant level.
RESULTS
Analysis of the Pattern of HPA-3 Gene Polymorphism Among Different Populations
Eight available reports concerning the pattern of HPA-3 gene polymorphism among different populations (1,2,5-10) were selected for further analysis in this study. The quoted HPA-3 gene polymorphism pattern is shown in Table 1 . The correlation is shown in Table 2 . The significant correlation between the population ethnicity and the gene frequencies was detected in this study (p < 0.05).
Analysis of the Pattern of HPA-3 Gene Polymorphism and Incidences of Some Important Disorders
Four available reports concerning the incidences of the immune neonatal thrombocytopenia were selected for further analysis in this study (1, 6, (11) (12) (13) (14) (15) (16) (Table 3 ). The correlation between the reported incidence of autoimmune neonatal disorders and the HPA-3 allele frequencies as well as heterogenicities reported in the same population was assessed. According to this study, the reported incidences of autoimmune neonatal disorders is not significantly correlated to neither allele frequency and heterogenicity (p > 0.05).
DISCUSSION
Human platelet antigens (HPA) are found on platelet membrane glycoproteins and are the target of platelet alloantibodies that mediate platelet destruction in NAIT, PTP, and refractoriness to platelet transfusion therapy (1) (2) (3) . The biallelic polymorphism of all HPA systems is known to be due to a substitution of a single base pair (3) . A number of previous studies were performed to investigate the frequency of the HPA genes in different population.
HPA-3 is a HPA that is mentioned for possible induction of neonatal alloimmune thrombocytopenia, posttransfusion purpura, and platelet refractoriness (1) (2) (3) . Several studies for genotypes of this HPA have been continuously performed in different populations (1,2,5-10).
Those studies, among different populations, would provide new data for geographical hematology, which has so far been based on erythrocyte, leukocyte, and serum polymorphisms. Here, the author performed a metanalysis on the previous reports on HPA-3 allele frequencies. The frequency ranges of HPA-3a and -3b from 0.50 to 0.61 and 0.38 to 0.50 can be demonstrated. According to the previous study of Chen and associates (17) , the strong association between the ethniticity of the population and the HPA-3 allele frequencies can be detected. In this work, the similar finding, a significant correlation between the population ethnicity and the gene frequencies, can be seen. At first the author set a hypothesis that the population from the same region of the world should present more similar HPA-3 gene polymorphism pattern than that from the other regions. The author first hypothesized that the similar trend of allele frequency among the Asian population and among the western population should be detected. Here, the clear pattern of a/b polymorphism of HPA-3 gene from various countries was shown in Table 2 . Of interest, the author found that some populations fit the hypothesis and some do not. Although some in the same regions have similar frequencies, the others from quite distinct regions could show similar frequencies as well. For example, Taiwan against Taiwan gives the difference equal to 0 while Taiwan against Finland gives a difference equal to 0. Although the similar trend of allele frequencies of some thrombohemostatic-related gene polymorphisms, such as acetylcholinesterase inhibitor gene polymorphism (4), among the populations in the same regions can be demonstrated, the author cannot find that observation in HPA-3 gene polymorphism. Conclusively, it is quite difficult to use the HPA-3 gene as a gene marker to determine similarity of gene populations in different populations. Although there is slight variation between populations, it is not a discrete difference.
In addition, the comparison of the heterogenicity of HPA-3 frequencies to HPA-1 gene demonstrates that there is a greater variation in HPA-3 frequencies than in the HPA-1 gene (1, 5, 6, 10, (17) (18) (19) (20) (Table 4 ). Given that many populations are predomiantely heterozygous for HPA-3 system the incidence of homozygosity and resultant clinical impact would be useful. To analyze the pattern of HPA-3 gene polymorphism and its clinical impacts on some important disorders, the author tries to correlate the gene frequency with the incidence of immune neonatal thrombocytopenia in different populations.
The clinical impact of HPA-3 gene frequency and variation on immune neonatal thrombocytopenia was assessed. There was no significant correlation between incidence of neonatal autoimmune thrombocytopenia disorders and HPA-3 gene polymorphism pattern. According to these findings, the impact of HPA-3 gene polymor-phism on prevalence of neonatal autoimmune disorders is limited. However, there is a limitation in our analysis; the studied incidences of neonatal autoimmune thrombocytopenia are not specific to HPA-3. Because there are only few data on the incidence of HPA-3, specific neonatal autoimmune thrombocytopenia cannot be further analyzed. In the case of HPA-3 specific autoimmune thrombocytopenia, the difference in pattern of a/b polymorphism of HPA-3 gene may be important in relation to the risk of neonatal autoimmune thrombocytopenia. (20) 
